ARCHIVES

Growth in Research Capacity Explains Increased Competition, NIH Director Tells NCAB.

This article is from The Cancer Letter archive.

Vol. 32 No. 23 | June 16, 2006

Download PDF Visit The Full Archive

Related Articles

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009

In Brief: Gertrude Elion, Nobel Laureae Whose Work Led To New Drugs For Cancer, Dead at 81

February 26, 1999

High Radiation Dose Effective Ten Years After Treatment

November 28, 2003

Intercultural Cancer Council Endorses New NCI Office

July 5, 1996

Beahrs Report Urges Mammography Continuation, Says BCDDPs Effective In Detecting Early Cancer

September 17, 1977

Phase III Xilonix Study Halted Following Unscheduled Analysis

September 26, 2014